Journal article
The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients
Anne Sofie Hogh Kolbaek Kjaer, Christel Rothe Brinkmann, Charles A Dinarello, Rikke Olesen, Lars Ostergaard, Ole Schmeltz Sogaard, Martin Tolstrup, Thomas Aagaard Rasmussen
AIDS | LIPPINCOTT WILLIAMS & WILKINS | Published : 2015
Grants
Awarded by NIH
Funding Acknowledgements
The study was funded by the Institute of Clinical Medicine at Aarhus University, by The Danish Council for Strategic Research and by NIH Grant AI-15614 (to C.A.D.). Novartis provided panobinostat for the study.